Patent details

EP1066052 Title: MESENCHYMAL STEM CELLS FOR PREVENTION AND TREATMENT OF IMMUNE RESPONSES IN TRANSPLANTATION

Basic Information

Publication number:
EP1066052
PCT Application Number:
PCT/US/1999/005548
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP999138761
PCT Publication Number:
WO/1999/047163
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MESENCHYMAL STEM CELLS FOR PREVENTION AND TREATMENT OF IMMUNE RESPONSES IN TRANSPLANTATION
French Title of Invention:
CELLULES DE SOUCHE MESENCHYMATEUSE SERVANT A LA PREVENTION ET AU TRAITEMENT DES REPONSES IMMUNITAIRES LORS DE LA TRANSPLANTATION
German Title of Invention:
MESENCHYMALE STAMMZELLEN FÜR DIE PRÄVENTION UND BEHANDLUNG VON IMMUNANTWORTEN BEI TRANSPLANTATIONEN
SPC Number:

Dates

Filing date:
12/03/1999
Grant date:
01/02/2006
EP Publication Date:
01/02/2006
PCT Publication Date:
23/09/1999
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/01/2001
EP B1 Publication Date:
01/02/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/03/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/06/2018
 
 

Name:
Mesoblast International Sàrl
Address:
Route de Pré-Bois 20, 1217 Meyrin, Switzerland (CH)

History of Owners

From:
06/06/2018
To:
06/06/2018

Name:
Osiris Therapeutics, Inc.
Address:
7015 Albert Einstein Drive, Columbia, MD 21046, United States (US)

From:
12/03/1999
To:
06/06/2018

Name:
Osiris Therapeutics Inc.
Address:
2001 Aliceanna Street, Baltimore, MD 21231-2001, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/04/2006
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MOSCA Joseph, D.
Address:
United States (US)

2

Name:
McINTOSH Kevin, R.
Address:
United States (US)

3

Name:
KLYUSHNENKOVA Elena, N.
Address:
United States (US)

Priority

1

Priority Number:
78463 P
Priority Date:
18/03/1998
Priority Country:
United States (US)

2

Priority Number:
89964 P
Priority Date:
19/06/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2018/08
Publication date:
06/07/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
CO
Bulletin edition number:
2018/08
Publication date:
06/07/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20180000210A
Date Registered:
06/06/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Changement d'adresse
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Osiris Therapeutics, Inc.
Address:
7015 Albert Einstein Drive, Columbia, MD 21046, United States (US)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20180000212A
Date Registered:
06/06/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Mesoblast International Sàrl
Address:
Route de Pré-Bois 20, 1217 Meyrin, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/02/2018
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
06/06/2018 Request For Change 4
07/06/2018 Outgoing Correspondence 1